ND Global, a leading provider of Clinical Trial Associate services, is proud to announce its groundbreaking partnership with Aurabiosciences, a trailblazer in the development of innovative oncology targeted therapies. This collaboration marks a significant milestone in the pursuit of providing cutting-edge solutions to address critical unmet needs in cancer treatment.

Aurabiosciences is at the forefront of creating a new class of oncology targeted therapies designed to deliver substantial therapeutic benefits across a spectrum of cancer indications with high unmet need. The company’s pioneering Virus-Like Drug Conjugate (VDC) technology platform represents a promising advancement in the field of ocular and urologic oncology.

Through this strategic partnership, ND Global will extend its Clinical Trial Associate services to Aurabiosciences, offering essential support in the critical phases of clinical research. Additionally, ND Global will leverage its expertise to provide top-tier staffing solutions for both temporary and permanent positions within Aurabiosciences, ensuring the right talent is in place to drive forward these groundbreaking initiatives.

About ND Global: ND Global offers complete life sciences services. Our expertise spans regulatory compliance, quality assurance, and top-tier staffing, making us the go-to hub for comprehensive support. With a commanding presence in a variety of industries within the life science sector – from Medical Devices and Pharmaceuticals to Biotechnology – ND Global is your ultimate solution for all your needs.